Metaraminol (tartrate)

Metaraminol tartrate (Metaradrine tartrate) is an α-adrenergic agonist[1]. Metaraminol tartrate is a sympathomimetic amine that directly and indirectly affects adrenergic receptors, with alpha effects being predominant.Metaraminol tartrate acts as a vasopressor agent[2].

Product Specifications

CAS Number

[33402-03-8]

Product Name Alternative

Metaradrine (tartrate)

UNSPSC

12352005

Hazard Statement

H301+H311+H331

Target

Adrenergic Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

COVID-19-immunoregulation

Field of Research

Cardiovascular Disease; Endocrinology

Assay Protocol

https://www.medchemexpress.com/Metaraminol-tartrate.html

Concentration

10mM

Purity

99.90

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(O)[C@H](O)[C@@H](O)C(O)=O.OC1=CC=CC([C@@H](O)[C@@H](N)C)=C1

Molecular Formula

C13H19NO8

Molecular Weight

317.29

Precautions

H301+H311+H331

References & Citations

[1]C Tong, et al. The vascular mechanism of ephedrine's beneficial effect on uterine perfusion during pregnancy. Anesthesiology. 1992 May;76 (5) :792-8.|[2]WESLEY W. SPINK, et al. Evaluation of Plasma, Metaraminol, and Hydrocortisone in Experimental Endotoxm Shock.|[3]P J Tutton, D H Barkla. The influence of adrenoceptor activity on cell proliferation in colonic crypt ipithelium and in colonic adenocarcinomata. Virchows Arch B Cell Pathol. 1977 Jun 24;24 (2) :139-46.